title: Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor.
abstract: A great deal of effort has been made over the years to develop liposomes that have targeting vectors (oligosaccharides, peptides, proteins and vitamins) attached to the bilayer surface. Most studies have focused on antibody conjugates since procedures for producing highly specific monoclonal antibodies are well established. Antibody conjugated liposomes have recently attracted a great deal of interest, principally because of their potential use as targeted drug delivery systems and in diagnostic applications. A number of methods have been reported for coupling antibodies to the surface of stealth liposomes. The objective of this review is to enumerate various strategies which are employed in the modification and conjugation of antibodies to the surface of stealth liposomes. This review also describes various derivatization techniques of lipids prior and after their use in the preparation of liposomes. The use of single chain variable fragments and affibodies as targeting ligands in the preparation of immunoliposomes is also discussed.
authors.affiliation: TIFAC CORE in NDDS, Pharmacy Department, M.S. University of Baroda, Fatehgunj, Vadodara-390 002, Gujarat, India.
authors.forename: Arehalli S
authors.initials: AS
authors.lastname: Manjappa
authors.forename: Kiran R
authors.initials: KR
authors.lastname: Chaudhari
authors.forename: Makam P
authors.initials: MP
authors.lastname: Venkataraju
authors.forename: Prudhviraju
authors.initials: P
authors.lastname: Dantuluri
authors.forename: Biswarup
authors.initials: B
authors.lastname: Nanda
authors.forename: Chennakesavulu
authors.initials: C
authors.lastname: Sidda
authors.forename: Krutika K
authors.initials: KK
authors.lastname: Sawant
authors.forename: Rayasa S Ramachandra
authors.initials: RS
authors.lastname: Murthy
mesh_terms: D000818:Animals; D000906:Antibodies / Q000737:chemistry* / Q000276:immunology; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D018796:Immunoconjugates / Q000737:chemistry* / Q000276:immunology; D008081:Liposomes / Q000737:chemistry* / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy
chemical_list: D000906:Antibodies; D000970:Antineoplastic Agents; D018796:Immunoconjugates; D008081:Liposomes